Intravenous valproic acid in the treatment of severe catatonia

被引:27
作者
Bräunig, P
机构
[1] Univ Toronto, Toronto, ON, Canada
[2] Univ Leipzig, D-7010 Leipzig, Germany
关键词
D O I
10.1176/appi.neuropsych.13.2.303
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:303 / 304
页数:2
相关论文
共 7 条
[1]   Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: A case-control study [J].
Berardi, D ;
Amore, M ;
Keck, PE ;
Troia, M ;
Dell'Atti, M .
BIOLOGICAL PSYCHIATRY, 1998, 44 (08) :748-754
[2]   Catatonia and the neuroleptics: Psychobiologic significance of remote and recent findings [J].
Blumer, D .
COMPREHENSIVE PSYCHIATRY, 1997, 38 (04) :193-201
[3]   The Catatonia Rating Scale I -: Development, reliability, and use [J].
Bräunig, P ;
Krüger, S ;
Shugar, G ;
Höffler, J ;
Börner, I .
COMPREHENSIVE PSYCHIATRY, 2000, 41 (02) :147-158
[4]  
Carroll BT, 1999, MOVEMENT DISORD, V14, P702, DOI 10.1002/1531-8257(199907)14:4<702::AID-MDS1027>3.0.CO
[5]  
2-N
[6]  
RANKEL HW, 1988, AM J PSYCHIAT, V145, P361
[7]  
Tunnicliff G, 1999, J PHYSIOL PHARMACOL, V50, P347